Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID

TC Theoharides, D Kempuraj - Cells, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

The biology of symptom-based disorders–time to act

A Goebel, D Andersson, Y Shoenfeld - Autoimmunity Reviews, 2023 - Elsevier
Symptom-based disorders are conditions that are characterised mostly by somatic
symptoms rather than objectively identifiable signs. They are very common, including pain …

Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy …

L Andreoli, CB Chighizola, L Iaccarino, A Botta… - Autoimmunity …, 2023 - Elsevier
Autoimmune rheumatic diseases (ARD) can affect women and men during fertile age,
therefore reproductive health is a priority issue in rheumatology. Many topics need to be …

A patient who recovered from post-COVID myalgic encephalomyelitis/chronic fatigue syndrome: a case report

T Oka - BioPsychoSocial Medicine, 2023 - Springer
Background Some patients infected with the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) complain of persistent fatigue, dyspnea, pain, and cognitive dysfunction …

Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”

A Dotan, Y Shoenfeld - Pathogens, 2023 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first reported in
December 2019, has infected numerous subjects worldwide. SARS-CoV-2 is the virus that …

Interaction between vitamin D deficiency and COVID-19

V Borba, P Carrera-Bastos - … , COVID-19, Post-COVID19 Syndrome and …, 2023 - Elsevier
Abstracts Coronavirus Disease 2019 (COVID-19) poses an enormous challenge to health
care systems throughout the world, but it doesn't affect every individual to the same extent …

Intravenous immunoglobulin and convalescent plasma treatment in the COVID-19 patient

MG Danieli, A Paladini, E Antonelli - Autoimmunity, COVID-19, Post …, 2023 - Elsevier
The severe acute respiratory coronavirus 2 (SARS-CoV-2), responsible for COVID-19
disease, proved to cause the activation of the innate and adaptive immune system in a small …

Treatment and prevention of the post-COVID syndrome

N Gavrilova, S Lidiia, VA Ryabkova, L Maria… - … , COVID-19, Post …, 2023 - Elsevier
In December 2019, one of the most severe pandemics in modern history, COVID-19
infection, originated in China, which led to the devastating consequences in the global …

Long-term assessment of autoantibodies in post-COVID syndrome

N Gavrilova, A Malkova, S Lidiia, VA Ryabkova… - … , COVID-19, Post …, 2023 - Elsevier
Novel coronavirus infection remains to be one of the most serious issues of the modern
health care, mainly, due to its prevalence and insufficient knowledge of the pathogenesis of …

[HTML][HTML] Влияние санаторно-курортного лечения на уровень системного воспаления у пациентов, перенёсших новую коронавирусную инфекцию

ВА Белоглазов, ЛШ Дудченко, ИА Яцков… - Acta Biomedica …, 2023 - cyberleninka.ru
Обоснование. Низкоинтенсивное воспаление (НИВ) на данный момент является одним
из главных факторов риска развития неблагоприятных событий со стороны сердечно …